SE8303003D0 - Medel for att oka antitumorverkan hos antitumormedel - Google Patents

Medel for att oka antitumorverkan hos antitumormedel

Info

Publication number
SE8303003D0
SE8303003D0 SE8303003A SE8303003A SE8303003D0 SE 8303003 D0 SE8303003 D0 SE 8303003D0 SE 8303003 A SE8303003 A SE 8303003A SE 8303003 A SE8303003 A SE 8303003A SE 8303003 D0 SE8303003 D0 SE 8303003D0
Authority
SE
Sweden
Prior art keywords
antitumor
agents
diltiazem
acid addition
agent
Prior art date
Application number
SE8303003A
Other languages
English (en)
Other versions
SE462076B (sv
SE8303003L (sv
Inventor
Y Sakurai
T Tsuruo
Original Assignee
Japan Found Cancer
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Found Cancer, Tanabe Seiyaku Co filed Critical Japan Found Cancer
Publication of SE8303003D0 publication Critical patent/SE8303003D0/sv
Publication of SE8303003L publication Critical patent/SE8303003L/sv
Publication of SE462076B publication Critical patent/SE462076B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SE8303003A 1982-05-28 1983-05-27 Antitoemoerkomposition innehaallande diltiazem och ett antitoemoermedel som utvaeljs bland vincristin och doxorubicin, samt anvaendning av diltiazem foer framstaellning av ett antitumoermedel med potentierad verkan SE462076B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57091850A JPS58208222A (ja) 1982-05-28 1982-05-28 抗腫瘍剤効果増強剤

Publications (3)

Publication Number Publication Date
SE8303003D0 true SE8303003D0 (sv) 1983-05-27
SE8303003L SE8303003L (sv) 1983-11-29
SE462076B SE462076B (sv) 1990-05-07

Family

ID=14038043

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303003A SE462076B (sv) 1982-05-28 1983-05-27 Antitoemoerkomposition innehaallande diltiazem och ett antitoemoermedel som utvaeljs bland vincristin och doxorubicin, samt anvaendning av diltiazem foer framstaellning av ett antitumoermedel med potentierad verkan

Country Status (11)

Country Link
US (1) US4628047A (sv)
JP (1) JPS58208222A (sv)
BE (1) BE896872A (sv)
CH (1) CH654212A5 (sv)
DE (1) DE3319347A1 (sv)
DK (1) DK239883A (sv)
FR (1) FR2527441B1 (sv)
GB (1) GB2120941B (sv)
IT (1) IT1208480B (sv)
NL (1) NL8301913A (sv)
SE (1) SE462076B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59231018A (ja) * 1983-06-10 1984-12-25 Tanabe Seiyaku Co Ltd 抗脂血剤
FR2593395A1 (fr) * 1986-01-28 1987-07-31 Corbiere Jerome Nouvelles compositions pharmaceutiques antiglaucomateuses a base de 3-acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4-one ou d'un de ses sels et leur procede d'obtention
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
DE3705117A1 (de) * 1987-02-18 1988-09-01 Goedecke Ag Verwendung von benzothiazepin-derivaten, insbesondere diltiazem bei der protektion von lymphozyten
US5112954A (en) * 1988-02-26 1992-05-12 Neorx Corporation Method of enhancing the effect of cytotoxic agents
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5208238A (en) * 1989-06-19 1993-05-04 Burroughs Wellcome Company Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
WO1990015599A1 (en) * 1989-06-19 1990-12-27 The Wellcome Foundation Limited Medicaments useful in cancer therapy and having antihistaminic properties
GB8914061D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914062D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914060D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914040D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
CA2030159A1 (en) * 1989-11-22 1991-05-23 Nahed K. Ahmed Anti-cancer drug potentiators
CA2030160A1 (en) * 1989-11-22 1991-05-23 Nahed K. Ahmed Benzothiazepine metastasis treatment
JPH0497451U (sv) * 1991-01-16 1992-08-24
GB2291279B (en) * 1994-06-24 1998-07-15 Thomas & Betts Corp Improvements in or relating to electrical connection apparatus
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof

Also Published As

Publication number Publication date
NL8301913A (nl) 1983-12-16
GB2120941A (en) 1983-12-14
DE3319347C2 (sv) 1992-03-19
IT8321348A0 (it) 1983-05-27
SE462076B (sv) 1990-05-07
GB8314588D0 (en) 1983-06-29
FR2527441B1 (fr) 1986-05-09
FR2527441A1 (fr) 1983-12-02
DK239883A (da) 1983-11-29
BE896872A (fr) 1983-09-16
GB2120941B (en) 1986-09-10
JPS6343366B2 (sv) 1988-08-30
JPS58208222A (ja) 1983-12-03
SE8303003L (sv) 1983-11-29
IT1208480B (it) 1989-07-10
DE3319347A1 (de) 1983-12-01
DK239883D0 (da) 1983-05-27
CH654212A5 (de) 1986-02-14
US4628047A (en) 1986-12-09

Similar Documents

Publication Publication Date Title
SE8303003D0 (sv) Medel for att oka antitumorverkan hos antitumormedel
EP0151989A3 (en) Means for the treatment of cardiac diseases
ES2055911T3 (es) Compuesto farmaceutico adelgazante.
IT1177553B (it) Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
NO832431L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
IT1187828B (it) Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO831610L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
DK0969843T3 (da) Antitussive formuleringer indeholdende theobromin
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
FR2547503B1 (fr) Nouveau systeme solvant-auxiliaire de penetration pour l'administration d'agents physiologiquement actifs par administration percutanee
NO164982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DE10299023I1 (de) Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
ATE79272T1 (de) Acth(1-24) enthaltende pharmazeutische zusammensetzungen zur therapie von schockzustaenden und von respiratorischen und herzkreislauf-insuffizienzen.
KR880003973A (ko) 약리적 활성 화합물 및 용도
NO832430L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyre-derivater
ES8603441A1 (es) Procedimiento para preparar un derivado de fenotiazina
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
NO833770L (no) Fremgangsmaate for fremstilling av terapeutisk aktive (1,2,4) triazolo (4,3-a) kinoksalin-4-amin-derivater
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO164599C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-d-mandelamido-3-(1-sulfometyl-tetrazol-5-yl)-tiometyl-3-cefem-4-karboksylsyre-mononatriumsalt.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8303003-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8303003-1

Format of ref document f/p: F